Integrin Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 2524 | A 205804 |
| Selective inhibitor of E-selectin and ICAM-1 expression | |
| 4228 | A 286982 |
| Potent inhibitor of the LFA-1/ICAM-1 interaction | |
| 6058 | ATN 161 |
| α5β1 integrin receptor antagonist | |
| 3910 | BIO 1211 |
| Selective α4β1 (VLA-4) inhibitor | |
| 5051 | BIO 5192 |
| Highly potent and selective inhibitor of integrin α4β1 (VLA-4) | |
| 4970 | BMS 688521 |
| Potent inhibitor of the LFA-1/ICAM interaction | |
| 6047 | BOP |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | |
| 4724 | BTT 3033 |
| Selective inhibitor of integrin α2β1 | |
| 5870 | Cilengitide |
| Potent and selective inhibitor of integrins αvβ3 and αvβ5 | |
| 6785 | E 7820 |
| α2 integrin inhibitor; anti-angiogenic | |
| 3202 | Echistatin, α1 isoform |
| αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor | |
| 7508 | EMD 527040 hydrochloride |
| ανβ6 integrin inhibitor | |
| 7059 | GLPG 0187 |
| Potent αv integrin inhibitor | |
| 1263 | GR 144053 trihydrochloride |
| Glycoprotein IIb/IIIa (integrin αIIbβ3) receptor antagonist. Antithrombotic | |
| 5114 | K34c |
| Potent and selective α5β1 integrin inhibitor | |
| 4664 | Obtustatin |
| Potent and selective α1β1 inhibitor | |
| 3498 | RGDS peptide |
| Integrin binding sequence; inhibits integrin receptor function | |
| 4527 | TC-I 15 |
| Potent α2β1 inhibitor; displays antithrombotic activity in vivo | |
| 3900 | TCS 2314 |
| α4β1 (VLA-4) antagonist |
Angiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDFDeveloping New Chemical Tools
This poster highlights the development of a library of Degrader builiding blocks and new fluorescent probes by Tocris Scientists
Request PDF